Zobrazeno 1 - 10
of 43
pro vyhledávání: '"zafer Ugur"'
Autor:
Sangeetha Vishweswaraiah, Sumeyya Akyol, Ali Yilmaz, Zafer Ugur, Juozas Gordevičius, Kyung Joon Oh, Patrik Brundin, Uppala Radhakrishna, Viviane Labrie, Stewart F. Graham
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
Parkinson’s disease (PD) is second most prevalent neurodegenerative disorder following Alzheimer’s disease. Parkinson’s disease is hypothesized to be caused by a multifaceted interplay between genetic and environmental factors. Herein, and for
Externí odkaz:
https://doaj.org/article/4e5cb75fdff04f49bba0fcfc9dbc0b47
Autor:
Sumeyya Akyol, Zafer Ugur, Ali Yilmaz, Ilyas Ustun, Santosh Kapil Kumar Gorti, Kyungjoon Oh, Bernadette McGuinness, Peter Passmore, Patrick G. Kehoe, Michael E. Maddens, Brian D. Green, Stewart F. Graham
Publikováno v:
Cells, Vol 10, Iss 10, p 2591 (2021)
Alzheimer’s disease (AD) is reported to be closely linked with abnormal lipid metabolism. To gain a more comprehensive understanding of what causes AD and its subsequent development, we profiled the lipidome of postmortem (PM) human brains (neocort
Externí odkaz:
https://doaj.org/article/7e97e7aa856a4300b1114c825dd147b9
Autor:
Ali Yilmaz, Zafer Ugur, Ilyas Ustun, Sumeyya Akyol, Ray O. Bahado-Singh, Michael Maddens, Jan O. Aasly, Stewart F. Graham
Publikováno v:
Cells, Vol 9, Iss 11, p 2394 (2020)
CSF from unique groups of Parkinson’s disease (PD) patients was biochemically profiled to identify previously unreported metabolic pathways linked to PD pathogenesis, and novel biochemical biomarkers of the disease were characterized. Utilizing bot
Externí odkaz:
https://doaj.org/article/271de77f580c4175a68e23da7922feda
Autor:
Ali Yilmaz, Zafer Ugur, Halil Bisgin, Sumeyya Akyol, Ray Bahado-Singh, George Wilson, Khaled Imam, Michael E. Maddens, Stewart F. Graham
Publikováno v:
Metabolites, Vol 10, Iss 9, p 357 (2020)
The lack of sensitive and specific biomarkers for the early detection of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is a major hurdle to improving patient management. A targeted, quantitative metabolomics approach using both 1H NM
Externí odkaz:
https://doaj.org/article/2eb252d2910a4b199b67fb8898d4d4a3
Autor:
Ashna M. Lalwani, Ali Yilmaz, Halil Bisgin, Zafer Ugur, Sumeyya Akyol, Stewart Francis Graham
Publikováno v:
Metabolites, Vol 10, Iss 6, p 261 (2020)
Epilepsy not-otherwise-specified (ENOS) is one of the most common causes of chronic disorders impacting human health, with complex multifactorial etiology and clinical presentation. Understanding the metabolic processes associated with the disorder m
Externí odkaz:
https://doaj.org/article/d29af9481c804b17bd4fc43cb70d3330
Autor:
Zeynep Alpay Savasan, Ali Yilmaz, Zafer Ugur, Buket Aydas, Ray O. Bahado-Singh, Stewart F. Graham
Publikováno v:
Metabolites, Vol 9, Iss 2, p 27 (2019)
Cerebral palsy (CP) is one of the most common causes of motor disability in childhood, with complex and heterogeneous etiopathophysiology and clinical presentation. Understanding the metabolic processes associated with the disease may aid in the disc
Externí odkaz:
https://doaj.org/article/80f0b93e68fc4eb8bd6086cf354569d2
Autor:
Ali Yilmaz, Ray Bahado Singh, Amy Whitten, Faryal Jafar, Onur Turkoglu, Ilyas Ustun, Perry Friedman, Stewart F. Graham, Zafer Ugur
To identify maternal second and third trimester urine metabolomic biomarkers for the detection of fetal congenital heart defects (CHDs). This was a prospective study. Metabolomic analysis of randomly collected maternal urine was performed, comparing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541e17e33cee53ec8607ce2efcbe0819
Autor:
Stewart F. Graham, Nolwen L. Rey, Zafer Ugur, Ali Yilmaz, Eric Sherman, Michael Maddens, Ray O. Bahado-Singh, Katelyn Becker, Emily Schulz, Lindsay K. Meyerdirk, Jennifer A. Steiner, Jiyan Ma, Patrik Brundin
Publikováno v:
Metabolites, Vol 8, Iss 4, p 71 (2018)
For people with Parkinson’s disease (PD), considered the most common neurodegenerative disease behind Alzheimer’s disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodromal phases of the d
Externí odkaz:
https://doaj.org/article/0003ce4bbc2641999a3bd8d919795571
Autor:
Bernadette McGuinness, Michael Maddens, Patrick G. Kehoe, Peter Passmore, Santosh Kapil Kumar Gorti, Brian D. Green, Stewart F. Graham, Ilyas Ustun, Kyungjoon Oh, Sumeyya Akyol, Ali Yilmaz, Zafer Ugur
Publikováno v:
Akyol, S, Ugur, Z, Yilmaz, A, Ustun, I, Gorti, S K K, Oh, K, McGuinness, B, Passmore, P, Kehoe, P G, Maddens, M E, Green, B D & Graham, S F 2021, ' Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism ', Cells, vol. 10, no. 10, 2591 . https://doi.org/10.3390/cells10102591
Cells
Volume 10
Issue 10
Cells, Vol 10, Iss 2591, p 2591 (2021)
Cells
Volume 10
Issue 10
Cells, Vol 10, Iss 2591, p 2591 (2021)
Alzheimer’s disease (AD) is reported to be closely linked with abnormal lipid metabolism. To gain a more comprehensive understanding of what causes AD and its subsequent development, we profiled the lipidome of postmortem (PM) human brains (neocort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e066e3bfe5f063a32dd6607f052061
https://pure.qub.ac.uk/en/publications/lipid-profiling-of-alzheimers-disease-brain-highlights-enrichment-in-glycerolphospholipid-and-sphingolipid-metabolism(d540628a-9ac2-40ea-b443-85965feac9d0).html
https://pure.qub.ac.uk/en/publications/lipid-profiling-of-alzheimers-disease-brain-highlights-enrichment-in-glycerolphospholipid-and-sphingolipid-metabolism(d540628a-9ac2-40ea-b443-85965feac9d0).html
Autor:
Michael Maddens, William T. Hu, Sumeyya Akyol, Ilyas Ustun, Ali Yilmaz, Massimo S. Fiandaca, Stewart F. Graham, Mark Mapstone, Howard J. Federoff, Zafer Ugur
Publikováno v:
Journal of Alzheimer's disease : JAD. 78(4)
Background: Currently, there is no objective, clinically available tool for the accurate diagnosis of Alzheimer’s disease (AD). There is a pressing need for a novel, minimally invasive, cost friendly, and easily accessible tool to diagnose AD, asse